Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
Katelyn A Pastick(Fairview Health Services), David R. Boulware(University of Minnesota Medical Center), Matthew F Pullen(Fairview Health Services), Sylvain Lother(Fairview Health Services), Emily G. McDonald(McGill University), Emili Letang(Hospital Del Mar), Lauren E. Kelly(Fairview Health Services), Elizabeth C Okafor(Fairview Health Services), Todd C. Lee(McGill University Health Centre), Sarah M Lofgren(Fairview Health Services), Radha Rajasingham(University of Minnesota System), Caleb P Skipper(University of Minnesota Medical Center), Ilan S. Schwartz(Fairview Health Services), Mahsa Abassi(University of Minnesota Medical Center), Fan Wang(Shanxi Agricultural University), Melanie R. Nicol(University of Minnesota)
Cited by 215
Related Papers
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548
Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2
|JAMA Internal Medicine|2021|327
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis
|Clinical Microbiology and Infection|2022|287